- Home
- SLRX vs CRNX Comparison
SLRX vs CRNX Comparison
Compare SLRX & CRNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SLRX | CRNX |
|---|---|---|
| Founded | N/A | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.6M | 4.1B |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | SLRX | CRNX |
|---|---|---|
| Price | $0.80 | $50.13 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 11 |
| Target Price | N/A | ★ $71.00 |
| AVG Volume (30 Days) | 660.6K | ★ 1.1M |
| Earning Date | 11-14-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $1,535,000.00 |
| Revenue This Year | N/A | $425.31 |
| Revenue Next Year | N/A | $943.50 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 47.74 |
| 52 Week Low | $0.71 | $24.10 |
| 52 Week High | $108.00 | $60.25 |
Technical Indicators
Market Signals| Indicator | SLRX | CRNX |
|---|---|---|
| Relative Strength Index (RSI) | 26.09 | 72.28 |
| Support Level | $0.81 | $46.49 |
| Resistance Level | $0.89 | $49.29 |
| Average True Range (ATR) | 0.07 | 1.96 |
| MACD | 0.10 | 0.41 |
| Stochastic Oscillator | 0.00 | 94.31 |
Price Performance
Historical ComparisonAbout SLRX Salarius Pharmaceuticals Inc.
Salarius Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing effective treatments for cancers with high, unmet medical needs. The company has focused on two classes of drugs that address gene dysregulation: targeted protein inhibitors and targeted protein degradation. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader.
About CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.